| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656727 | Médecine des Maladies Métaboliques | 2016 | 8 Pages |
Abstract
The aim of this article is to present an update on past and recent knowledge on endocannabinoids and metabolism, and future perspectives for the treatment of metabolic disorders, including dyslipidemia associated with the metabolic syndrome.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
A.-L. Sberna, P. Degrace, B. Vergès,